3 Stocks Pushing The Health Care Sector Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 156 points (1.0%) at 15,978 as of Friday, Dec. 6, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 2,203 issues advancing vs. 732 declining with 103 unchanged.

The Health Care sector currently sits up 0.5% versus the S&P 500, which is up 0.9%. A company within the sector that fell today was Teva Pharmaceutical Industries ( TEVA), up 0.6%. Top gainers within the sector include Boston Scientific ( BSX), up 4.2%, Cigna ( CI), up 2.5%, Intuitive Surgical ( ISRG), up 2.2%, Thermo Fisher Scientific ( TMO), up 2.0% and Agilent Technologies ( A), up 2.0%.

TheStreet would like to highlight 3 stocks pushing the sector lower today:

3. Cooper Companies ( COO) is one of the companies pushing the Health Care sector lower today. As of noon trading, Cooper Companies is down $7.89 (-5.9%) to $125.84 on heavy volume. Thus far, 1.1 million shares of Cooper Companies exchanged hands as compared to its average daily volume of 280,700 shares. The stock has ranged in price between $125.05-$127.40 after having opened the day at $126.66 as compared to the previous trading day's close of $133.73.

The Cooper Companies, Inc. operates as a medical device company worldwide. Cooper Companies has a market cap of $6.5 billion and is part of the health services industry. The company has a P/E ratio of 21.1, above the S&P 500 P/E ratio of 17.7. Shares are up 44.6% year to date as of the close of trading on Thursday. Currently there are 7 analysts that rate Cooper Companies a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Cooper Companies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Cooper Companies Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Herbalife ( HLF) is down $2.48 (-3.2%) to $73.96 on heavy volume. Thus far, 2.1 million shares of Herbalife exchanged hands as compared to its average daily volume of 2.8 million shares. The stock has ranged in price between $71.54-$76.95 after having opened the day at $76.84 as compared to the previous trading day's close of $76.43.

Herbalife Ltd., through its subsidiaries, produces and distributes weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, and personal care products worldwide. Herbalife has a market cap of $7.7 billion and is part of the consumer non-durables industry. The company has a P/E ratio of 15.7, below the S&P 500 P/E ratio of 17.7. Shares are up 132.0% year to date as of the close of trading on Thursday. Currently there are 6 analysts that rate Herbalife a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Herbalife as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Herbalife Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Bristol-Myers Squibb Company ( BMY) is down $0.35 (-0.7%) to $50.45 on average volume. Thus far, 3.4 million shares of Bristol-Myers Squibb Company exchanged hands as compared to its average daily volume of 7.3 million shares. The stock has ranged in price between $50.30-$51.31 after having opened the day at $51.20 as compared to the previous trading day's close of $50.80.

Bristol-Myers Squibb Company, a biopharmaceutical company, discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products that help patients prevail over serious diseases worldwide. Bristol-Myers Squibb Company has a market cap of $84.1 billion and is part of the drugs industry. The company has a P/E ratio of 30.8, above the S&P 500 P/E ratio of 17.7. Shares are up 55.9% year to date as of the close of trading on Thursday. Currently there are 9 analysts that rate Bristol-Myers Squibb Company a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates Bristol-Myers Squibb Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, solid stock price performance, impressive record of earnings per share growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Bristol-Myers Squibb Company Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Video: You Could Live in a Ritz-Carlton or St. Regis Home